Ferric Derisomaltose Evaluation in Patients with Non-Dialysis-Dependent Chronic Kidney Disease or Peritoneal Dialysis.
The Canadian journal of hospital pharmacy（2023）
摘要
This study provides evidence that FDI is an effective and safe treatment for anemia in NDD-CKD and PD patients.
更多查看译文
关键词
IV iron,anemia,chronic kidney disease,ferric derisomaltose,iron isomaltoside,peritoneal dialysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要